nodes	percent_of_prediction	percent_of_DWPC	metapath
Astemizole—CYP2D6—Fingolimod—multiple sclerosis	0.111	0.121	CbGbCtD
Astemizole—ABCB1—Methylprednisolone—multiple sclerosis	0.0759	0.083	CbGbCtD
Astemizole—CYP3A4—Fingolimod—multiple sclerosis	0.0705	0.0772	CbGbCtD
Astemizole—CYP3A7—Dexamethasone—multiple sclerosis	0.0588	0.0643	CbGbCtD
Astemizole—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0588	0.0643	CbGbCtD
Astemizole—ABCB1—Mitoxantrone—multiple sclerosis	0.0553	0.0606	CbGbCtD
Astemizole—ABCB1—Betamethasone—multiple sclerosis	0.0493	0.054	CbGbCtD
Astemizole—ABCB1—Prednisolone—multiple sclerosis	0.0487	0.0533	CbGbCtD
Astemizole—ABCB1—Prednisone—multiple sclerosis	0.046	0.0503	CbGbCtD
Astemizole—CYP3A4—Methylprednisolone—multiple sclerosis	0.0455	0.0498	CbGbCtD
Astemizole—CYP3A5—Dexamethasone—multiple sclerosis	0.0441	0.0483	CbGbCtD
Astemizole—CYP3A4—Triamcinolone—multiple sclerosis	0.0344	0.0377	CbGbCtD
Astemizole—CYP3A4—Mitoxantrone—multiple sclerosis	0.0332	0.0363	CbGbCtD
Astemizole—CYP3A4—Betamethasone—multiple sclerosis	0.0296	0.0323	CbGbCtD
Astemizole—CYP3A4—Prednisolone—multiple sclerosis	0.0292	0.0319	CbGbCtD
Astemizole—ABCB1—Dexamethasone—multiple sclerosis	0.0287	0.0314	CbGbCtD
Astemizole—CYP3A4—Prednisone—multiple sclerosis	0.0275	0.0301	CbGbCtD
Astemizole—CYP2D6—Dexamethasone—multiple sclerosis	0.027	0.0296	CbGbCtD
Astemizole—ABCB1—Methotrexate—multiple sclerosis	0.0231	0.0252	CbGbCtD
Astemizole—CYP3A4—Dexamethasone—multiple sclerosis	0.0172	0.0188	CbGbCtD
Astemizole—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	0.000369	0.00427	CbGpPWpGaD
Astemizole—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000364	0.00421	CbGpPWpGaD
Astemizole—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000364	0.00421	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000359	0.00416	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000359	0.00416	CbGpPWpGaD
Astemizole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000357	0.00413	CbGpPWpGaD
Astemizole—HRH1—IL-4 Signaling Pathway—IL4—multiple sclerosis	0.000345	0.00399	CbGpPWpGaD
Astemizole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000333	0.00385	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000327	0.00378	CbGpPWpGaD
Astemizole—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000323	0.00373	CbGpPWpGaD
Astemizole—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000323	0.00373	CbGpPWpGaD
Astemizole—HRH1—G alpha (q) signalling events—GPR65—multiple sclerosis	0.000313	0.00362	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—SRM—multiple sclerosis	0.00031	0.00359	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000308	0.00357	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000294	0.0034	CbGpPWpGaD
Astemizole—CYP2J2—Biological oxidations—POMC—multiple sclerosis	0.000288	0.00333	CbGpPWpGaD
Astemizole—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000285	0.0033	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000281	0.00325	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.00028	0.00324	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.00028	0.00324	CbGpPWpGaD
Astemizole—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000266	0.00308	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000262	0.00303	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000262	0.00303	CbGpPWpGaD
Astemizole—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000259	0.00299	CbGpPWpGaD
Astemizole—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000259	0.00299	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000257	0.00297	CbGpPWpGaD
Astemizole—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—multiple sclerosis	0.000256	0.00296	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000243	0.00281	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000242	0.0028	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—BCHE—multiple sclerosis	0.000241	0.00279	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000236	0.00273	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000226	0.00261	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000224	0.00259	CbGpPWpGaD
Astemizole—HRH1—IL-4 Signaling Pathway—TYK2—multiple sclerosis	0.000223	0.00258	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000221	0.00256	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CYP27B1—multiple sclerosis	0.000219	0.00253	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CYP24A1—multiple sclerosis	0.000219	0.00253	CbGpPWpGaD
Astemizole—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000216	0.0025	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000215	0.00249	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000214	0.00247	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000212	0.00245	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000207	0.0024	CbGpPWpGaD
Astemizole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000205	0.00237	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—GPC5—multiple sclerosis	0.0002	0.00232	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—S1PR1—multiple sclerosis	0.000196	0.00226	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000194	0.00224	CbGpPWpGaD
Astemizole—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000193	0.00223	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000189	0.00219	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000189	0.00219	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000187	0.00216	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000175	0.00202	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000171	0.00198	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000171	0.00198	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000169	0.00196	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000169	0.00196	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000168	0.00195	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—RRM1—multiple sclerosis	0.000166	0.00192	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000165	0.00191	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000165	0.00191	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.00016	0.00186	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—GPR65—multiple sclerosis	0.000158	0.00183	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000157	0.00182	CbGpPWpGaD
Astemizole—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000156	0.00181	CbGpPWpGaD
Astemizole—HRH1—IL-4 Signaling Pathway—STAT3—multiple sclerosis	0.000156	0.00181	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000152	0.00175	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—FAS—multiple sclerosis	0.000148	0.00171	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000147	0.0017	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	0.000147	0.0017	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000146	0.00169	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	0.000145	0.00168	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CCR1—multiple sclerosis	0.000144	0.00167	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CXCL13—multiple sclerosis	0.000144	0.00167	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000142	0.00165	CbGpPWpGaD
Astemizole—HRH1—IL-4 Signaling Pathway—MAPK1—multiple sclerosis	0.000142	0.00164	CbGpPWpGaD
Astemizole—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000137	0.00158	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000135	0.00156	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	0.000133	0.00154	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000131	0.00152	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00013	0.0015	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000129	0.00149	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000125	0.00145	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—SRM—multiple sclerosis	0.000124	0.00143	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—CD80—multiple sclerosis	0.000123	0.00142	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000122	0.00141	CbGpPWpGaD
Astemizole—CYP3A7—Biological oxidations—POMC—multiple sclerosis	0.000115	0.00133	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000113	0.0013	CbGpPWpGaD
Astemizole—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000111	0.00128	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000111	0.00128	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.00011	0.00128	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000109	0.00126	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000107	0.00124	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000106	0.00123	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CCL3—multiple sclerosis	0.000103	0.00119	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000101	0.00117	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000101	0.00117	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—S1PR1—multiple sclerosis	0.0001	0.00116	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—PTGER4—multiple sclerosis	9.89e-05	0.00114	CbGpPWpGaD
Astemizole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	9.88e-05	0.00114	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	9.7e-05	0.00112	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CXCR3—multiple sclerosis	9.56e-05	0.00111	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—BCHE—multiple sclerosis	9.52e-05	0.0011	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—RGS1—multiple sclerosis	9.4e-05	0.00109	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CCR2—multiple sclerosis	9.3e-05	0.00108	CbGpPWpGaD
Astemizole—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	9.18e-05	0.00106	CbGpPWpGaD
Astemizole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.95e-05	0.00104	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—SRM—multiple sclerosis	8.95e-05	0.00104	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—GPR65—multiple sclerosis	8.91e-05	0.00103	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	8.73e-05	0.00101	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	8.72e-05	0.00101	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	8.72e-05	0.00101	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	8.65e-05	0.001	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	8.62e-05	0.000998	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL2—multiple sclerosis	8.62e-05	0.000998	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CNR1—multiple sclerosis	8.58e-05	0.000993	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—RGS1—multiple sclerosis	8.54e-05	0.000988	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	8.53e-05	0.000987	CbGpPWpGaD
Astemizole—CYP3A5—Biological oxidations—POMC—multiple sclerosis	8.29e-05	0.00096	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.28e-05	0.000958	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CXCL13—multiple sclerosis	8.15e-05	0.000943	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CCR1—multiple sclerosis	8.15e-05	0.000943	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—GPR65—multiple sclerosis	8.09e-05	0.000937	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—GPC5—multiple sclerosis	7.98e-05	0.000923	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	7.87e-05	0.00091	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—LINGO1—multiple sclerosis	7.83e-05	0.000906	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CXCL10—multiple sclerosis	7.72e-05	0.000894	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CXCL13—multiple sclerosis	7.4e-05	0.000857	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CCR1—multiple sclerosis	7.4e-05	0.000857	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	7.38e-05	0.000854	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	7.3e-05	0.000845	CbGpPWpGaD
Astemizole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.26e-05	0.00084	CbGpPWpGaD
Astemizole—KCNH2—Neuronal System—MAPK1—multiple sclerosis	7.05e-05	0.000816	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TAGAP—multiple sclerosis	6.79e-05	0.000785	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—SRM—multiple sclerosis	6.75e-05	0.000781	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	6.72e-05	0.000778	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CCL5—multiple sclerosis	6.65e-05	0.000769	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—RRM1—multiple sclerosis	6.61e-05	0.000765	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.54e-05	0.000757	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—SRM—multiple sclerosis	6.36e-05	0.000736	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	6.3e-05	0.00073	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	6.3e-05	0.00073	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—TNF—multiple sclerosis	6.28e-05	0.000727	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	6.15e-05	0.000711	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	6.01e-05	0.000696	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CCR5—multiple sclerosis	5.99e-05	0.000693	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—S1PR1—multiple sclerosis	5.93e-05	0.000686	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—POMC—multiple sclerosis	5.9e-05	0.000682	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.79e-05	0.00067	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—GPC5—multiple sclerosis	5.77e-05	0.000668	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—GPC5—multiple sclerosis	5.77e-05	0.000667	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—APOE—multiple sclerosis	5.73e-05	0.000663	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—PTGER4—multiple sclerosis	5.59e-05	0.000647	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CXCR3—multiple sclerosis	5.4e-05	0.000625	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CCL3—multiple sclerosis	5.27e-05	0.00061	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CCR2—multiple sclerosis	5.25e-05	0.000608	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—PTGER4—multiple sclerosis	5.08e-05	0.000588	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—RGS1—multiple sclerosis	5.04e-05	0.000584	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—POMC—multiple sclerosis	4.92e-05	0.000569	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CXCR3—multiple sclerosis	4.9e-05	0.000567	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CNR1—multiple sclerosis	4.85e-05	0.000561	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—GPR65—multiple sclerosis	4.78e-05	0.000553	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—RRM1—multiple sclerosis	4.78e-05	0.000553	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CCR2—multiple sclerosis	4.77e-05	0.000552	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP24A1—multiple sclerosis	4.76e-05	0.00055	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP27B1—multiple sclerosis	4.76e-05	0.00055	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.69e-05	0.000543	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—POMC—multiple sclerosis	4.68e-05	0.000542	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CCL2—multiple sclerosis	4.58e-05	0.00053	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—ALB—multiple sclerosis	4.49e-05	0.000519	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	4.48e-05	0.000519	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	4.48e-05	0.000519	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CNR1—multiple sclerosis	4.4e-05	0.000509	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CCR1—multiple sclerosis	4.37e-05	0.000506	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CXCL13—multiple sclerosis	4.37e-05	0.000506	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CXCL10—multiple sclerosis	4.36e-05	0.000505	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—GPC5—multiple sclerosis	4.35e-05	0.000503	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—SRM—multiple sclerosis	4.16e-05	0.000481	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—GPC5—multiple sclerosis	4.1e-05	0.000474	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CXCL10—multiple sclerosis	3.96e-05	0.000459	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.85e-05	0.000446	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—BCHE—multiple sclerosis	3.8e-05	0.000439	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CCL5—multiple sclerosis	3.76e-05	0.000435	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.61e-05	0.000417	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—RRM1—multiple sclerosis	3.6e-05	0.000417	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CCL5—multiple sclerosis	3.41e-05	0.000395	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.4e-05	0.000393	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CCR5—multiple sclerosis	3.38e-05	0.000392	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—IL2RA—multiple sclerosis	3.34e-05	0.000386	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.33e-05	0.000385	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.32e-05	0.000384	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.25e-05	0.000377	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CCL3—multiple sclerosis	3.12e-05	0.000361	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	3.1e-05	0.000359	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	3.07e-05	0.000356	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	3.03e-05	0.000351	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	3e-05	0.000347	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—PGR—multiple sclerosis	2.95e-05	0.000342	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.93e-05	0.000339	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.93e-05	0.000339	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	2.9e-05	0.000335	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CD28—multiple sclerosis	2.87e-05	0.000332	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CCR2—multiple sclerosis	2.82e-05	0.000326	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—BCHE—multiple sclerosis	2.74e-05	0.000318	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.68e-05	0.00031	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	2.65e-05	0.000306	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CNR1—multiple sclerosis	2.6e-05	0.000301	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—POMC—multiple sclerosis	2.4e-05	0.000278	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	2.35e-05	0.000272	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	2.34e-05	0.000271	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—APOE—multiple sclerosis	2.28e-05	0.000264	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.22e-05	0.000257	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	2.13e-05	0.000247	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.08e-05	0.000241	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—BCHE—multiple sclerosis	2.07e-05	0.00024	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CD86—multiple sclerosis	2.05e-05	0.000237	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CCL5—multiple sclerosis	2.02e-05	0.000233	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—POMC—multiple sclerosis	1.96e-05	0.000227	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	1.96e-05	0.000226	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.95e-05	0.000226	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—SPP1—multiple sclerosis	1.87e-05	0.000216	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CCR5—multiple sclerosis	1.82e-05	0.00021	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	1.79e-05	0.000207	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—ALB—multiple sclerosis	1.79e-05	0.000207	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—IL2—multiple sclerosis	1.78e-05	0.000206	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—APOE—multiple sclerosis	1.65e-05	0.000191	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—APOE—multiple sclerosis	1.65e-05	0.000191	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CD80—multiple sclerosis	1.49e-05	0.000173	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—POMC—multiple sclerosis	1.42e-05	0.000164	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—POMC—multiple sclerosis	1.42e-05	0.000164	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CCL2—multiple sclerosis	1.39e-05	0.000161	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	1.36e-05	0.000157	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—ALB—multiple sclerosis	1.29e-05	0.00015	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.28e-05	0.000148	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TYK2—multiple sclerosis	1.26e-05	0.000146	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—APOE—multiple sclerosis	1.25e-05	0.000144	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—APOE—multiple sclerosis	1.17e-05	0.000136	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—POMC—multiple sclerosis	1.07e-05	0.000124	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IL2—multiple sclerosis	1.05e-05	0.000121	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—IL6—multiple sclerosis	1.04e-05	0.000121	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—POMC—multiple sclerosis	1.01e-05	0.000117	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MMP9—multiple sclerosis	9.93e-06	0.000115	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—ALB—multiple sclerosis	9.76e-06	0.000113	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—ALB—multiple sclerosis	9.19e-06	0.000106	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—STAT3—multiple sclerosis	8.83e-06	0.000102	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MYC—multiple sclerosis	8.2e-06	9.49e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	8.18e-06	9.47e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	8.03e-06	9.29e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—APOE—multiple sclerosis	7.67e-06	8.88e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—POMC—multiple sclerosis	6.59e-06	7.63e-05	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IL6—multiple sclerosis	6.17e-06	7.14e-05	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—ALB—multiple sclerosis	6.01e-06	6.96e-05	CbGpPWpGaD
